Clin2
NCT06914557Possibly a fitRecruiting

Scrambler therapy plus duloxetine for chemo nerve pain

CIPN - Chemotherapy-Induced Peripheral NeuropathyPain

Part of Pain clinical trials.

This study tests whether adding a non-invasive device called Scrambler Therapy to the usual nerve pain medicine (duloxetine) can better relieve chemotherapy-induced nerve pain. It is for people with cancer who still have significant nerve pain despite taking duloxetine.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
50 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 or older and have had cancer
  • You have nerve pain or numbness in your hands or feet that started or got worse after chemotherapy
  • You are already taking duloxetine (Cymbalta) at least 30 mg daily for at least 4 weeks
  • Your average nerve pain level is at least 4 out of 10
  • You are not taking gabapentin (unless you can safely stop) and do not have a pacemaker or other implanted device
  • You are not pregnant, nursing, or have severe depression or epilepsy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07219472Recruiting
Scrambler therapy for nerve pain from chemotherapy

This trial tests a non-invasive treatment called Scrambler Therapy for pain caused by nerve damage from chemotherapy. If you have had this kind of pain for at least 3 months, this therapy might help reduce it without using more drugs.

Cleveland, Ohio
NCT04970121Recruiting· Phase 2
Duloxetine for chemotherapy nerve pain in solid tumor patients

This Phase 2 trial tests duloxetine to see if it safely reduces painful nerve damage caused by chemotherapy (especially taxanes) in people with solid tumors. If you have moderate-to-severe nerve pain and meet lab and heart-safety checks, this study may be an option.

Bengbu, Anhui
NCT07601386Not yet recruiting· Phase 1
New medicine for chemotherapy nerve pain

This study tests a new medicine (JMKX000189) to see if it can safely reduce nerve pain, tingling, or numbness that comes from chemotherapy. If you have this side effect after cancer treatment, this trial might offer a new way to feel better.

Shanghai
NCT06522685Not yet recruiting
Brain stimulation for chemotherapy nerve pain

This study tests a non-invasive brain stimulation treatment to see if it can reduce nerve pain caused by chemotherapy. It also looks at how the treatment affects the brain and immune system.

Baltimore, Maryland
NCT07174609Recruiting
Scrambler therapy for chronic pancreatitis pain

This study tests a non-invasive pain treatment called scrambler therapy for people with chronic pancreatitis. It uses mild electrical signals on the skin to try to reduce long-term belly pain.

Baltimore, Maryland
NCT06596200Not yet recruiting· Phase 4
Spinal cord stimulation for chemotherapy nerve pain

This trial tests whether a spinal cord stimulator, a small device that sends gentle electrical signals to block pain, can relieve nerve pain caused by chemotherapy. If you have ongoing numbness or burning in your hands or feet after treatment, this study might help you feel better and improve your quality of life.

Hear when a new Pain trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.